Cetera Advisor Networks’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $663K | Sell |
4,806
-941
| -16% | -$130K | ﹤0.01% | 1743 |
|
|
2023
Q4 | $757K | Buy |
5,747
+9
| +0.2% | +$1.19K | ﹤0.01% | 1567 |
|
|
2023
Q3 | $646K | Buy |
5,738
+1,481
| +35% | +$167K | ﹤0.01% | 1590 |
|
|
2023
Q2 | $401K | Buy |
4,257
+1,665
| +64% | +$157K | ﹤0.01% | 1877 |
|
|
2023
Q1 | $262K | Buy |
2,592
+441
| +21% | +$44.6K | ﹤0.01% | 2135 |
|
|
2022
Q4 | $257K | Buy |
+2,151
| New | +$257K | ﹤0.01% | 2097 |
|
|
2020
Q3 | – | Sell |
-103
| Closed | -$13K | – | 2366 |
|
|
2020
Q2 | $13K | Buy |
+103
| New | +$13K | ﹤0.01% | 2607 |
|